Načítá se...
Current regulatory approaches for accessing potential COVID-19 therapies
This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe...
Uloženo v:
| Vydáno v: | J Pharm Policy Pract |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229878/ https://ncbi.nlm.nih.gov/pubmed/32454981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-020-00222-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|